# A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors

> **NCT01351519** · PHASE2 · TERMINATED · sponsor: **MultiCare Health System Research Institute** · enrollment: 16 (actual)

## Conditions studied

- Malignant Glioma
- Glioma
- Glioblastoma
- Glioblastoma Multiforme
- Astrocytoma

## Interventions

- **DRUG:** Aminolevulinic Acid

## Key facts

- **NCT ID:** NCT01351519
- **Lead sponsor:** MultiCare Health System Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Limited staff available for enrollment and limited availability of drug
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01351519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01351519, "A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01351519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*